Rebecca Pearl

Associate Researcher
rebecca.pearl@mssm.edu

Recent Publications

Evaluation of new adjuvants in enhancing the immune response to a candidate of Severe Fever with Thrombocytopenia Syndrome Virus vaccine October 1, 2026 Jorge Levican
In situ APMV-4 vaccination primes systemic response to subtherapeutic dosing of aCTLA-4 in colorectal carcinoma September 28, 2026 Yonina Bykov
Substitutions affecting the HA-NA-receptor balance preceded the emergence of the pandemic 2009 H1N1 virus September 23, 2026 Katherine Marougka
Small molecule inhibition of the mitochondrial lipid transfer protein STARD7 attenuates influenza viral replication September 11, 2026 Shipra Sharma
A bireporter recombinant SARS-CoV-2 Omicron BA.5 for in vitro and in vivo studies September 10, 2026 Esteban M Castro
A One-Shot Multivalent Live-Attenuated Candidate Influenza Vaccine against Divergent Zoonotic H5N1 Clades August 20, 2026 Ahmed M Elsayed
Characterization and validation of EHR computable phenotypes for Long COVID using patient-reported symptoms: insights from the nationwide RECOVER program July 24, 2026 Victor M Castro
Post-vaccination expansion of extrafollicular Th10 and regulatory Tfr cells distinguishes strong from weak influenza vaccine responses in older adults July 17, 2026 Avinash S Mahajan
A potential RNA-RNA distal interaction competing with a functional pseudoknot in the 3'-untranslated region of SARS-like coronaviruses July 15, 2026 Sergio López-Núñez
Lineage dynamics and risk factors underlying serotype 4 invasive pneumococcal disease in Spain June 30, 2026 Covadonga Pérez-García
Phase 1 trial of intranasal NDV-HXP-S in previously vaccinated adults June 30, 2026 Sean T H Liu
Compartmentalized cytokine networks and systemic immune remodelling in bovine mammary H5N1 infection June 6, 2026 Gagandeep Singh
Zoonotic infections and genomic evolution of novel reassortant swine influenza A viruses in Spain June 5, 2026 Paloma A Encinas
CEIRR Risk Assessment Pipeline executive reports on H5N1 highly pathogenic avian influenza 2.3.4.4b, swine H1 1B.2, and H9N2 low pathogenicity avian influenza B4.7.2 June 3, 2026 Centers of Excellence for Influenza Research and Response Risk Assessment Pipeline
Identification and characterization of a SARS-CoV-2 Mpro G23 deletion ensitrelvir-resistant mutant June 3, 2026 Yao Ma

Upcoming Events

Click here to view a calendar with upcoming events.